AL21 Stock Overview
Veradigm Inc., a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Veradigm Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$6.20 |
| 52 Week High | US$13.00 |
| 52 Week Low | US$5.25 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | -27.06% |
| 1 Year Change | -45.61% |
| 3 Year Change | -52.67% |
| 5 Year Change | -24.81% |
| Change since IPO | 138.46% |
Recent News & Updates
Recent updates
Shareholder Returns
| AL21 | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | 0% | -1.3% | -1.7% |
| 1Y | -45.6% | -23.1% | 1.4% |
Return vs Industry: AL21 underperformed the German Healthcare Services industry which returned -23.1% over the past year.
Return vs Market: AL21 underperformed the German Market which returned 1.4% over the past year.
Price Volatility
| AL21 volatility | |
|---|---|
| AL21 Average Weekly Movement | 15.2% |
| Healthcare Services Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 9.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: AL21's share price has been volatile over the past 3 months.
Volatility Over Time: AL21's weekly volatility has increased from 8% to 15% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | n/a | Shih-Yin Ho | veradigm.com |
Veradigm Inc., a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates through two segments, Hospitals and Large Physician Practices, and Veradigm.
Veradigm Inc. Fundamentals Summary
| AL21 fundamental statistics | |
|---|---|
| Market cap | €760.68m |
| Earnings (TTM) | €109.08m |
| Revenue (TTM) | €1.44b |
0.0x
P/E Ratio0.0x
P/S RatioIs AL21 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AL21 income statement (TTM) | |
|---|---|
| Revenue | US$1.53b |
| Cost of Revenue | US$754.78m |
| Gross Profit | US$774.22m |
| Other Expenses | US$658.31m |
| Earnings | US$115.91m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did AL21 perform over the long term?
See historical performance and comparison